Molecular and structural characterization of ureido-benzenesulfonamides as dual inhibitors of aldose reductase and cholinesterases
 
Yazarlar (5)
Prof. Dr. Cüneyt Türkeş Erzincan Binali Yıldırım Üniversitesi, Türkiye
Doç. Dr. Nebih Lolak Adıyaman Üniversitesi, Türkiye
Doç. Dr. Hatice Esra DURAN Kafkas Üniversitesi, Türkiye
Doç. Dr. Gönül Yapar İstanbul Teknik Üniversitesi, Türkiye
Doç. Dr. Süleyman Akocak Adıyaman Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (Q1)
Dergi ISSN 0003-9861 Dergi Bilgileri (2025)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 11-2025
Cilt / Sayı / Sayfa 773 / 0 / 110594–0 DOI 10.1016/j.abb.2025.110594
Makale Linki https://doi.org/10.1016/j.abb.2025.110594
UAK Araştırma Alanları
Tıbbi Biyokimya
Özet
The conformational and kinetic intricacies of enzyme-ligand interactions are critical for understanding molecular mechanisms underlying metabolic and neurodegenerative pathologies. Herein, we report a rationally designed series of ureido-benzenesulfonamides as dual-acting nanomolar inhibitors targeting aldose reductase (ALR2) and cholinesterases (AChE and BChE). Spectrophotometric inhibition assays revealed that compound 3SA-a displayed exceptional ALR2 affinity (KI = 7.00 ± 0.68 nM), surpassing epalrestat by over 30-fold. Likewise, 3SA-f selectively inhibited BChE with a KI of 24.20 ± 2.26 nM, outperforming tacrine by a factor of 7.8. Molecular docking simulations highlighted distinct dynamic binding modes: 3SA-a engaged ALR2’s catalytic cleft through a hydrogen bond with Tyr48 and water-bridged interactions, whereas 3SA-f leveraged π-π stacking and halogen bonding within BChE’s extended …
Anahtar Kelimeler
Ureido-benzenesulfonamides | Aldose reductase | Cholinesterase inhibition | Molecular docking | Structure-activity relationship
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 17
Google Scholar 21
Molecular and structural characterization of ureido-benzenesulfonamides as dual inhibitors of aldose reductase and cholinesterases

Paylaş